[3] Schett G, Mackensen A, Mougiakakos D. CAR T-cell therapy in autoimmune diseases. Lancet. 2023 Nov 25;402(10416):2034-2044. doi: 10.1016/S0140-6736(23)01126-1. Epub 2023 Sep 22. PMID: 37748491.链接：https://pubmed.ncbi.nlm.nih.gov/37748491/ [4]Wang W, He S, Zhang W,...
2023年9月， Nature子刊“nature reviews drug discovery”上发表了一篇影响因子为120.1（Q1 IF=120.1），名为“The next-generation CAR-T therapy landscape”的研究报告[1]，系统阐述了下一代CAR-T疗法的治疗前景。下一代CAR-T疗法除了治疗血液系统恶性肿瘤以外，还将应用于其他肿瘤甚至非肿瘤性疾病，通过对CA...
2023年,Cancer Communications期刊上发表了题为“Combined local therapy and CAR-GPC3 T-cell therapy in advanced hepatocellular carcinoma: a proof-of-concept treatment strategy”的研究论文,旨在探究局部治疗加CAR-GPC3 T细胞治疗是否对晚期肝细胞癌患...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986336/ [2]Rendo MJ,et al.CAR T-Cell Therapy for Patients with Multiple Myeloma: Current Evidence and Challenges. Blood Lymphat Cancer. 2022 Aug 29;12:119-136. doi: 10.2147/BLCTT.S327016.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC943...
想寻求CAR-T疗法帮助或参与临床试验获得天价疗法免费治疗机会的患者，可将治疗经历、近期影像学及病理检查结果等，提交至医学部，进行初步评估!参考资料 [1]Neelapu S S,et al.Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial[J]. Nature ...
[1] Long-term outcomes following CAR T cell therapy: what we know so far https://www.nature.com/articles/s41571-023-00754-1 [2] T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma.https://pubmed.ncbi.nlm.nih.gov/27412889/ ...
Consolidative radiotherapy for residual fluorodeoxyglucose activity on day +30 post CAR T-cell therapy in non-Hodgkin lymphoma 第一作者:Saifi O Haematologica (IF=10.1). 2023 Nov 1;108(11):2982-2992. 全文网址:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620596/ ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293002/ [2]https://pci.upenn.edu/good-morning-america-features-story-of-emily-whitehead-the-first-pediatric-patient-to-receive-car-t-cell-therapy/ [3]https://www.chop....
ncbi.nlm.nih.gov/pmc/articles/PMC9284423/ [4]Che Y,et al.Recent advances in CAR T-cell therapy for lymphoma in China. Clin Transl Oncol. 2023 Oct;25(10):2793-2800.doi: 10.1007/s12094-023-03153-1. Epub 2023 Apr 16.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462491/ ...
[1]Marhelava K,et al.CAR-T Cells Shoot for New Targets: Novel Approaches to Boost Adoptive Cell Therapy for B Cell-Derived Malignancies. Cells. 2022 May 31;11(11):1804.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180412/ [2]Zhang,Y,et al.Safety and efficacy of a novel anti-CD19...